In an alternative approach to xenograft models that would enable in vivo studies of CT-179 in models with typical MB heterogeneity and tumor microenvironment (TME), we analyzed CT-179 treatment in transgenic Gfap-Cre/SmoM2 (G-Smo) mice. This evidence concerns the gene GFAP and neoplasm.